Zealand Pharma crashes 26% as obesity drug’s side effects, dropouts disappoint

Investing.com Gold reports: Zealand Pharma crashes 26% as obesity drug’s side effects, dropouts disappoint. Full body text was unavailable at ingest time, so this brief is based on headline context.